For a decade, the IPF Summit has been the go-to, discussion-led forum uniting stakeholders across the pulmonary fibrosis ecosystem. In its 10th anniversary year, the stakes, and the opportunity, have never been higher.
Bringing together 150+ experts across discovery, translational science, and clinical development, from organizations including Bristol Myers Squibb, United Therapeutics, Boehringer Ingelheim, Pfizer, Novartis, AbbVie, PureTech Health, Insilico Medicine, and many more, the summit offers a uniquely integrated view of the scientific, clinical, and strategic decisions shaping the next decade of IPF innovation.
Whether you’re advancing early discovery, translating assets into the clinic, or positioning therapies in a crowded market, this is where the field aligns on what success now looks like, and how to achieve it.

Find out more about the 10th Anniversary Edition of the IPF Summit: https://ter.li/5dfb4ius